Surrogate endpoints are substitute measures used in clinical trials to predict the effect of a treatment on a true clinical outcome. They are often biomarker or laboratory measures that can be observed earlier than the actual clinical outcome, allowing for faster assessment of treatment efficacy. This is particularly important in the FDA approval processes, where timely evaluation of new drugs and devices can accelerate patient access to effective therapies.
congrats on reading the definition of Surrogate Endpoints. now let's actually learn it.